Pain Relief Medication Market 2028 By Drug Class, Indication, Distribution Channel | The Insight Partners

    Pain Relief Medication Market Forecast to 2028 - COVID-19 Impact and Global Analysis by Drug Class (Nonsteroidal Anti-Inflammatory Drugs, Opioids, Others); Indication (Cancer Pain, Neuropathic Pain, Musculoskeletal Pain, Others); Distribution Channel (Hospital and Retail Pharmacies, Online Pharmacies)

    Report Code: TIPRE00011963 | No. of Pages: 150 | Category: Pharmaceuticals | Status: Upcoming

    MARKET INTRODUCTION

    Pain relievers are medicines that relieve headaches, sore muscles, arthritis, or other aches and pains. There are many different pain medicines, and each one has advantages and risks. Some types of pain respond better to certain medications than others. Medication is a drug used to diagnose, cure, treat, or prevent disease. Drug therapy is an essential part of the medical field and relies on the science of pharmacology for continual advancement and pharmacy for appropriate management.

    MARKET DYNAMICS

    The pain relief medication market is driving due to the increasing expenditure capacity of the normal human beings, better inclusion in hospitals and various treatments. Moreover, hike in research funding, better drug development technology using AI and other advanced technologies, hike in clearance rate, government support boosts the growth of the market for pain relief medication.

    MARKET SCOPE

    The "Pain Relief Medication Market Analysis to 2028" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of pain relief medication market with detailed market segmentation by drug class, indication and distribution channel. The pain relief medication market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in pain relief medication market and offers key trends and opportunities in the market.

    MARKET SEGMENTATION

    The pain relief medication market is segmented on the basis of drug class, indication and distribution channel. Based on drug class, the market is segmented as nonsteroidal anti-inflammatory drugs, opioids and others. On the basis of indication, the market is categorized as cancer pain, neuropathic pain, musculoskeletal pain and others. On the basis of distribution channel, the market is categorized as hospital and retail pharmacies and online pharmacies.

    REGIONAL FRAMEWORK

    The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the pain relief medication market based on various segments. It also provides market size and forecast estimates from year 2020 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The pain relief medication market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

    The report analyzes factors affecting pain relief medication market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the pain relief medication market in these regions.




    Get more information on this report :

    MARKET PLAYERS


    The report covers key developments in the pain relief medication market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from pain relief medication market are anticipated to have lucrative growth opportunities in the future with the rising demand for pain relief medication in the global market. Below mentioned is the list of few companies engaged in the pain relief medication market.

    The report also includes the profiles of key players in pain relief medication market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.

    •   AbbVie Inc. (US)
    •   Allergan PLC (Ireland)
    •   Astellas Pharma Inc. (Japan)
    •   Bayer (Germany)
    •   Biogen Idec (US)
    •   Boehringer Ingelheim International GmbH (Germany)
    •   Bristol-Myers Squibb (US)
    •   Eli Lilly and Company (US)
    •   GlaxoSmithKline (UK)
    •   Mallinckrodt Pharmaceuticals (UK)
    •   Pfizer, Inc. (US)
    •   Purdue Pharma (US)
    •   Sanofi (France)


    The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.


    Get more information on this report :

    TABLE OF CONTENTS

    1. INTRODUCTION
    1.1. SCOPE OF THE STUDY
    1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
    1.3. MARKET SEGMENTATION
    1.3.1 Pain Relief Medication Market - By Drug Class
    1.3.2 Pain Relief Medication Market - By Indication
    1.3.3 Pain Relief Medication Market - By Distribution Channel
    1.3.4 Pain Relief Medication Market - By Region
    1.3.4.1 By Country
    2. KEY TAKEAWAYS
    3. RESEARCH METHODOLOGY
    4. PAIN RELIEF MEDICATION MARKET LANDSCAPE
    4.1. OVERVIEW
    4.2. PEST ANALYSIS
    4.2.1 North America - Pest Analysis
    4.2.2 Europe - Pest Analysis
    4.2.3 Asia-Pacific - Pest Analysis
    4.2.4 Middle East and Africa - Pest Analysis
    4.2.5 South and Central America - Pest Analysis
    4.3. EXPERT OPINIONS
    5. PAIN RELIEF MEDICATION MARKET - KEY MARKET DYNAMICS
    5.1. KEY MARKET DRIVERS
    5.2. KEY MARKET RESTRAINTS
    5.3. KEY MARKET OPPORTUNITIES
    5.4. FUTURE TRENDS
    5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
    6. PAIN RELIEF MEDICATION MARKET - GLOBAL MARKET ANALYSIS
    6.1. PAIN RELIEF MEDICATION - GLOBAL MARKET OVERVIEW
    6.2. PAIN RELIEF MEDICATION - GLOBAL MARKET AND FORECAST TO 2028
    6.3. MARKET POSITIONING/MARKET SHARE
    7. PAIN RELIEF MEDICATION MARKET - REVENUE AND FORECASTS TO 2028 - DRUG CLASS
    7.1. OVERVIEW
    7.2. DRUG CLASS MARKET FORECASTS AND ANALYSIS
    7.3. NONSTEROIDAL ANTI-INFLAMMATORY DRUGS
    7.3.1. Overview
    7.3.2. Nonsteroidal Anti-Inflammatory Drugs Market Forecast and Analysis
    7.4. OPIOIDS
    7.4.1. Overview
    7.4.2. Opioids Market Forecast and Analysis
    7.5. OTHERS
    7.5.1. Overview
    7.5.2. Others Market Forecast and Analysis
    8. PAIN RELIEF MEDICATION MARKET - REVENUE AND FORECASTS TO 2028 - INDICATION
    8.1. OVERVIEW
    8.2. INDICATION MARKET FORECASTS AND ANALYSIS
    8.3. CANCER PAIN
    8.3.1. Overview
    8.3.2. Cancer Pain Market Forecast and Analysis
    8.4. NEUROPATHIC PAIN
    8.4.1. Overview
    8.4.2. Neuropathic Pain Market Forecast and Analysis
    8.5. MUSCULOSKELETAL PAIN
    8.5.1. Overview
    8.5.2. Musculoskeletal Pain Market Forecast and Analysis
    8.6. OTHERS
    8.6.1. Overview
    8.6.2. Others Market Forecast and Analysis
    9. PAIN RELIEF MEDICATION MARKET - REVENUE AND FORECASTS TO 2028 - DISTRIBUTION CHANNEL
    9.1. OVERVIEW
    9.2. DISTRIBUTION CHANNEL MARKET FORECASTS AND ANALYSIS
    9.3. HOSPITAL AND RETAIL PHARMACIES
    9.3.1. Overview
    9.3.2. Hospital and Retail Pharmacies Market Forecast and Analysis
    9.4. ONLINE PHARMACIES
    9.4.1. Overview
    9.4.2. Online Pharmacies Market Forecast and Analysis
    10. PAIN RELIEF MEDICATION MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
    10.1. NORTH AMERICA
    10.1.1 North America Pain Relief Medication Market Overview
    10.1.2 North America Pain Relief Medication Market Forecasts and Analysis
    10.1.3 North America Pain Relief Medication Market Forecasts and Analysis - By Drug Class
    10.1.4 North America Pain Relief Medication Market Forecasts and Analysis - By Indication
    10.1.5 North America Pain Relief Medication Market Forecasts and Analysis - By Distribution Channel
    10.1.6 North America Pain Relief Medication Market Forecasts and Analysis - By Countries
    10.1.6.1 United States Pain Relief Medication Market
    10.1.6.1.1 United States Pain Relief Medication Market by Drug Class
    10.1.6.1.2 United States Pain Relief Medication Market by Indication
    10.1.6.1.3 United States Pain Relief Medication Market by Distribution Channel
    10.1.6.2 Canada Pain Relief Medication Market
    10.1.6.2.1 Canada Pain Relief Medication Market by Drug Class
    10.1.6.2.2 Canada Pain Relief Medication Market by Indication
    10.1.6.2.3 Canada Pain Relief Medication Market by Distribution Channel
    10.1.6.3 Mexico Pain Relief Medication Market
    10.1.6.3.1 Mexico Pain Relief Medication Market by Drug Class
    10.1.6.3.2 Mexico Pain Relief Medication Market by Indication
    10.1.6.3.3 Mexico Pain Relief Medication Market by Distribution Channel
    10.2. EUROPE
    10.2.1 Europe Pain Relief Medication Market Overview
    10.2.2 Europe Pain Relief Medication Market Forecasts and Analysis
    10.2.3 Europe Pain Relief Medication Market Forecasts and Analysis - By Drug Class
    10.2.4 Europe Pain Relief Medication Market Forecasts and Analysis - By Indication
    10.2.5 Europe Pain Relief Medication Market Forecasts and Analysis - By Distribution Channel
    10.2.6 Europe Pain Relief Medication Market Forecasts and Analysis - By Countries
    10.2.6.1 Germany Pain Relief Medication Market
    10.2.6.1.1 Germany Pain Relief Medication Market by Drug Class
    10.2.6.1.2 Germany Pain Relief Medication Market by Indication
    10.2.6.1.3 Germany Pain Relief Medication Market by Distribution Channel
    10.2.6.2 France Pain Relief Medication Market
    10.2.6.2.1 France Pain Relief Medication Market by Drug Class
    10.2.6.2.2 France Pain Relief Medication Market by Indication
    10.2.6.2.3 France Pain Relief Medication Market by Distribution Channel
    10.2.6.3 Italy Pain Relief Medication Market
    10.2.6.3.1 Italy Pain Relief Medication Market by Drug Class
    10.2.6.3.2 Italy Pain Relief Medication Market by Indication
    10.2.6.3.3 Italy Pain Relief Medication Market by Distribution Channel
    10.2.6.4 Spain Pain Relief Medication Market
    10.2.6.4.1 Spain Pain Relief Medication Market by Drug Class
    10.2.6.4.2 Spain Pain Relief Medication Market by Indication
    10.2.6.4.3 Spain Pain Relief Medication Market by Distribution Channel
    10.2.6.5 United Kingdom Pain Relief Medication Market
    10.2.6.5.1 United Kingdom Pain Relief Medication Market by Drug Class
    10.2.6.5.2 United Kingdom Pain Relief Medication Market by Indication
    10.2.6.5.3 United Kingdom Pain Relief Medication Market by Distribution Channel
    10.3. ASIA-PACIFIC
    10.3.1 Asia-Pacific Pain Relief Medication Market Overview
    10.3.2 Asia-Pacific Pain Relief Medication Market Forecasts and Analysis
    10.3.3 Asia-Pacific Pain Relief Medication Market Forecasts and Analysis - By Drug Class
    10.3.4 Asia-Pacific Pain Relief Medication Market Forecasts and Analysis - By Indication
    10.3.5 Asia-Pacific Pain Relief Medication Market Forecasts and Analysis - By Distribution Channel
    10.3.6 Asia-Pacific Pain Relief Medication Market Forecasts and Analysis - By Countries
    10.3.6.1 Australia Pain Relief Medication Market
    10.3.6.1.1 Australia Pain Relief Medication Market by Drug Class
    10.3.6.1.2 Australia Pain Relief Medication Market by Indication
    10.3.6.1.3 Australia Pain Relief Medication Market by Distribution Channel
    10.3.6.2 China Pain Relief Medication Market
    10.3.6.2.1 China Pain Relief Medication Market by Drug Class
    10.3.6.2.2 China Pain Relief Medication Market by Indication
    10.3.6.2.3 China Pain Relief Medication Market by Distribution Channel
    10.3.6.3 India Pain Relief Medication Market
    10.3.6.3.1 India Pain Relief Medication Market by Drug Class
    10.3.6.3.2 India Pain Relief Medication Market by Indication
    10.3.6.3.3 India Pain Relief Medication Market by Distribution Channel
    10.3.6.4 Japan Pain Relief Medication Market
    10.3.6.4.1 Japan Pain Relief Medication Market by Drug Class
    10.3.6.4.2 Japan Pain Relief Medication Market by Indication
    10.3.6.4.3 Japan Pain Relief Medication Market by Distribution Channel
    10.3.6.5 South Korea Pain Relief Medication Market
    10.3.6.5.1 South Korea Pain Relief Medication Market by Drug Class
    10.3.6.5.2 South Korea Pain Relief Medication Market by Indication
    10.3.6.5.3 South Korea Pain Relief Medication Market by Distribution Channel
    10.4. MIDDLE EAST AND AFRICA
    10.4.1 Middle East and Africa Pain Relief Medication Market Overview
    10.4.2 Middle East and Africa Pain Relief Medication Market Forecasts and Analysis
    10.4.3 Middle East and Africa Pain Relief Medication Market Forecasts and Analysis - By Drug Class
    10.4.4 Middle East and Africa Pain Relief Medication Market Forecasts and Analysis - By Indication
    10.4.5 Middle East and Africa Pain Relief Medication Market Forecasts and Analysis - By Distribution Channel
    10.4.6 Middle East and Africa Pain Relief Medication Market Forecasts and Analysis - By Countries
    10.4.6.1 South Africa Pain Relief Medication Market
    10.4.6.1.1 South Africa Pain Relief Medication Market by Drug Class
    10.4.6.1.2 South Africa Pain Relief Medication Market by Indication
    10.4.6.1.3 South Africa Pain Relief Medication Market by Distribution Channel
    10.4.6.2 Saudi Arabia Pain Relief Medication Market
    10.4.6.2.1 Saudi Arabia Pain Relief Medication Market by Drug Class
    10.4.6.2.2 Saudi Arabia Pain Relief Medication Market by Indication
    10.4.6.2.3 Saudi Arabia Pain Relief Medication Market by Distribution Channel
    10.4.6.3 U.A.E Pain Relief Medication Market
    10.4.6.3.1 U.A.E Pain Relief Medication Market by Drug Class
    10.4.6.3.2 U.A.E Pain Relief Medication Market by Indication
    10.4.6.3.3 U.A.E Pain Relief Medication Market by Distribution Channel
    10.5. SOUTH AND CENTRAL AMERICA
    10.5.1 South and Central America Pain Relief Medication Market Overview
    10.5.2 South and Central America Pain Relief Medication Market Forecasts and Analysis
    10.5.3 South and Central America Pain Relief Medication Market Forecasts and Analysis - By Drug Class
    10.5.4 South and Central America Pain Relief Medication Market Forecasts and Analysis - By Indication
    10.5.5 South and Central America Pain Relief Medication Market Forecasts and Analysis - By Distribution Channel
    10.5.6 South and Central America Pain Relief Medication Market Forecasts and Analysis - By Countries
    10.5.6.1 Brazil Pain Relief Medication Market
    10.5.6.1.1 Brazil Pain Relief Medication Market by Drug Class
    10.5.6.1.2 Brazil Pain Relief Medication Market by Indication
    10.5.6.1.3 Brazil Pain Relief Medication Market by Distribution Channel
    10.5.6.2 Argentina Pain Relief Medication Market
    10.5.6.2.1 Argentina Pain Relief Medication Market by Drug Class
    10.5.6.2.2 Argentina Pain Relief Medication Market by Indication
    10.5.6.2.3 Argentina Pain Relief Medication Market by Distribution Channel
    11. IMPACT OF COVID-19 PANDEMIC ON GLOBAL PAIN RELIEF MEDICATION MARKET
    11.1 North America
    11.2 Europe
    11.3 Asia-Pacific
    11.4 Rest of the World
    12. INDUSTRY LANDSCAPE
    12.1. MERGERS AND ACQUISITIONS
    12.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
    12.3. NEW PRODUCT LAUNCHES
    12.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
    13. PAIN RELIEF MEDICATION MARKET, KEY COMPANY PROFILES
    13.1. ABBVIE INC. (US)
    13.1.1. Key Facts
    13.1.2. Business Description
    13.1.3. Products and Services
    13.1.4. Financial Overview
    13.1.5. SWOT Analysis
    13.1.6. Key Developments
    13.2. ALLERGAN PLC (IRELAND)
    13.2.1. Key Facts
    13.2.2. Business Description
    13.2.3. Products and Services
    13.2.4. Financial Overview
    13.2.5. SWOT Analysis
    13.2.6. Key Developments
    13.3. ASTELLAS PHARMA INC. (JAPAN)
    13.3.1. Key Facts
    13.3.2. Business Description
    13.3.3. Products and Services
    13.3.4. Financial Overview
    13.3.5. SWOT Analysis
    13.3.6. Key Developments
    13.4. BAYER (GERMANY)
    13.4.1. Key Facts
    13.4.2. Business Description
    13.4.3. Products and Services
    13.4.4. Financial Overview
    13.4.5. SWOT Analysis
    13.4.6. Key Developments
    13.5. BIOGEN IDEC (US)
    13.5.1. Key Facts
    13.5.2. Business Description
    13.5.3. Products and Services
    13.5.4. Financial Overview
    13.5.5. SWOT Analysis
    13.5.6. Key Developments
    13.6. BOEHRINGER INGELHEIM INTERNATIONAL GMBH (GERMANY)
    13.6.1. Key Facts
    13.6.2. Business Description
    13.6.3. Products and Services
    13.6.4. Financial Overview
    13.6.5. SWOT Analysis
    13.6.6. Key Developments
    13.7. BRISTOL-MYERS SQUIBB (US)
    13.7.1. Key Facts
    13.7.2. Business Description
    13.7.3. Products and Services
    13.7.4. Financial Overview
    13.7.5. SWOT Analysis
    13.7.6. Key Developments
    13.8. ELI LILLY AND COMPANY (US)
    13.8.1. Key Facts
    13.8.2. Business Description
    13.8.3. Products and Services
    13.8.4. Financial Overview
    13.8.5. SWOT Analysis
    13.8.6. Key Developments
    13.9. GLAXOSMITHKLINE (UK)
    13.9.1. Key Facts
    13.9.2. Business Description
    13.9.3. Products and Services
    13.9.4. Financial Overview
    13.9.5. SWOT Analysis
    13.9.6. Key Developments
    13.10. MALLINCKRODT PHARMACEUTICALS (UK)
    13.10.1. Key Facts
    13.10.2. Business Description
    13.10.3. Products and Services
    13.10.4. Financial Overview
    13.10.5. SWOT Analysis
    13.10.6. Key Developments
    13.11. PFIZER, INC. (US)
    13.11.1. Key Facts
    13.11.2. Business Description
    13.11.3. Products and Services
    13.11.4. Financial Overview
    13.11.5. SWOT Analysis
    13.11.6. Key Developments
    13.12. PURDUE PHARMA (US)
    13.12.1. Key Facts
    13.12.2. Business Description
    13.12.3. Products and Services
    13.12.4. Financial Overview
    13.12.5. SWOT Analysis
    13.12.6. Key Developments
    13.13. SANOFI (FRANCE)
    13.13.1. Key Facts
    13.13.2. Business Description
    13.13.3. Products and Services
    13.13.4. Financial Overview
    13.13.5. SWOT Analysis
    13.13.6. Key Developments
    14. APPENDIX
    14.1. ABOUT THE INSIGHT PARTNERS
    14.2. GLOSSARY OF TERMS
    The List of Companies

    1. AbbVie Inc. (US)
    2. Allergan PLC (Ireland)
    3. Astellas Pharma Inc. (Japan)
    4. Bayer (Germany)
    5. Biogen Idec (US)
    6. Boehringer Ingelheim International GmbH (Germany)
    7. Bristol-Myers Squibb (US)
    8. Eli Lilly and Company (US)
    9. GlaxoSmithKline (UK)
    10. Mallinckrodt Pharmaceuticals (UK)
    11. Pfizer, Inc. (US)
    12. Purdue Pharma (US)
    13. Sanofi (France)
    TIPRE00011963
    Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

    Get the Latest COVID-19 Analysis on this market




    Have a question?

    Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.


    Speak To Analyst
    Pricing
    • $3000
    • $4550
    • $6550
    • $8550
        GET FREE SAMPLE PDF

    Sample PDF showcases the content structure and the nature of the information included in the report which presents a qualitative and quantitative analysis.

        Inquire for Discount